30 May2024Vesper Bio Announces Completion of Single Ascending Dose Stage In Trial of Its Lead Candidate VES001, A Potentially Disease-Modifying Treatment For Fronto-Temporal DementiaAuthor By Healthufit Posted on May 30, 2024May 30, 2024Vesper Bio Announces Completion of Single Ascending Dose Stage In Trial of...
08 Apr2024Vivet Therapeutics Doses First Patient In Cohort 2 In Phase 1/2 GATEWAY Clinical Trial For Treatment Of Wilson DiseaseAuthor By Healthufit Posted on April 8, 2024April 8, 2024Vivet Therapeutics Doses First Patient In Cohort 2 In Phase 1/2 GATEWAY Cli...
06 Mar2024Asceneuron Expands Scientific Advisory Board With World Leading Experts In Neurodegenerative DiseasesAuthor By Healthufit Posted on March 6, 2024March 6, 2024Asceneuron Expands Scientific Advisory Board With World Leading Experts In...